Insider Transactions in Q1 2023 at Neurocrine Biosciences Inc (NBIX)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 08
2023
|
Julie Cooke Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
1,328
-2.34%
|
$136,784
$103.82 P/Share
|
|
Feb 08
2023
|
Eiry Roberts Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
980
-2.33%
|
$101,920
$104.16 P/Share
|
|
Feb 08
2023
|
Malcolm Lloyd Smith Chief Integration Officer |
SELL
Open market or private sale
|
Direct |
701
-1.63%
|
$72,203
$103.83 P/Share
|
|
Feb 08
2023
|
Darin Lippoldt Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
911
-1.99%
|
$94,744
$104.08 P/Share
|
|
Feb 08
2023
|
Kyle Gano Chief Business Development Off |
SELL
Open market or private sale
|
Direct |
980
-0.76%
|
$100,940
$103.99 P/Share
|
|
Feb 08
2023
|
Kevin Charles Gorman Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,274
-0.46%
|
$236,496
$104.3 P/Share
|
|
Feb 08
2023
|
David W. Boyer Chief Corp. Affairs Officer |
SELL
Open market or private sale
|
Direct |
700
-12.83%
|
$72,800
$104.11 P/Share
|
|
Feb 08
2023
|
Matt Abernethy Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
980
-3.74%
|
$101,920
$104.19 P/Share
|
|
Feb 08
2023
|
Eric Benevich Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
980
-2.77%
|
$101,920
$104.12 P/Share
|
|
Feb 07
2023
|
Julie Cooke Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
14,536
-13.09%
|
$1,482,672
$102.9 P/Share
|
|
Feb 07
2023
|
Eiry Roberts Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
14,424
-14.77%
|
$1,471,248
$102.38 P/Share
|
|
Feb 07
2023
|
Malcolm Lloyd Smith Chief Integration Officer |
SELL
Open market or private sale
|
Direct |
13,816
-13.37%
|
$1,409,232
$102.29 P/Share
|
|
Feb 07
2023
|
Jude Onyia Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,508
-40.86%
|
$459,816
$102.3 P/Share
|
|
Feb 07
2023
|
Darin Lippoldt Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
14,323
-13.46%
|
$1,460,946
$102.33 P/Share
|
|
Feb 07
2023
|
Kyle Gano Chief Business Development Off |
SELL
Open market or private sale
|
Direct |
14,424
-5.26%
|
$1,471,248
$102.35 P/Share
|
|
Feb 07
2023
|
Kevin Charles Gorman Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
23,730
-2.35%
|
$2,420,460
$102.37 P/Share
|
|
Feb 07
2023
|
David W. Boyer Chief Corp. Affairs Officer |
SELL
Open market or private sale
|
Direct |
24,298
-59.31%
|
$2,478,396
$102.42 P/Share
|
|
Feb 07
2023
|
Matt Abernethy Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
26,328
-22.04%
|
$2,685,456
$102.38 P/Share
|
|
Feb 07
2023
|
Eric Benevich Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
17,390
-20.39%
|
$1,773,780
$102.36 P/Share
|
|
Feb 06
2023
|
Julie Cooke Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
1,215
-3.61%
|
$126,360
$104.88 P/Share
|
|
Feb 06
2023
|
Eiry Roberts Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,121
-3.96%
|
$117,705
$105.8 P/Share
|
|
Feb 06
2023
|
Malcolm Lloyd Smith Chief Integration Officer |
SELL
Open market or private sale
|
Direct |
801
-2.66%
|
$84,105
$105.82 P/Share
|
|
Feb 06
2023
|
Darin Lippoldt Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,041
-3.22%
|
$109,305
$105.8 P/Share
|
|
Feb 06
2023
|
Kyle Gano Chief Business Development Off |
SELL
Open market or private sale
|
Direct |
1,600
-1.38%
|
$168,000
$105.64 P/Share
|
|
Feb 06
2023
|
Kevin Charles Gorman Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,040
-0.65%
|
$319,200
$105.68 P/Share
|
|
Feb 06
2023
|
David W. Boyer Chief Corp. Affairs Officer |
SELL
Open market or private sale
|
Direct |
240
-5.5%
|
$25,200
$105.61 P/Share
|
|
Feb 06
2023
|
Matt Abernethy Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,280
-5.38%
|
$134,400
$105.67 P/Share
|
|
Feb 06
2023
|
Eric Benevich Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,280
-6.68%
|
$134,400
$105.63 P/Share
|
|
Jan 31
2023
|
Jude Onyia Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
126
-4.84%
|
$13,608
$108.48 P/Share
|
|
Jan 31
2023
|
Eiry Roberts Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,457
-5.27%
|
$158,813
$109.99 P/Share
|
|
Jan 31
2023
|
Darin Lippoldt Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,250
-3.95%
|
$136,250
$109.97 P/Share
|
|
Jan 31
2023
|
Malcolm Lloyd Smith Chief Integration Officer |
SELL
Open market or private sale
|
Direct |
1,666
-5.51%
|
$183,260
$110.02 P/Share
|
|
Jan 31
2023
|
Kyle Gano Chief Business Development Off |
SELL
Open market or private sale
|
Direct |
1,541
-1.35%
|
$167,969
$109.98 P/Share
|
|
Jan 31
2023
|
Kevin Charles Gorman Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,707
-0.58%
|
$297,770
$110.08 P/Share
|
|
Jan 31
2023
|
David W. Boyer Chief Corp. Affairs Officer |
SELL
Open market or private sale
|
Direct |
1,104
-22.01%
|
$120,336
$109.92 P/Share
|
|
Jan 31
2023
|
Julie Cooke Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
916
-5.44%
|
$98,928
$108.48 P/Share
|
|
Jan 31
2023
|
Eric Benevich Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,207
-6.73%
|
$131,563
$109.95 P/Share
|
|
Jan 31
2023
|
Matt Abernethy Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,283
-5.67%
|
$139,847
$109.98 P/Share
|
|
Jan 06
2023
|
Eric Benevich Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
400
-2.49%
|
$50,000
$125.0 P/Share
|
|
Jan 06
2023
|
Eric Benevich Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
400
+2.43%
|
$17,200
$43.24 P/Share
|
|
Jan 03
2023
|
Stephen A Sherwin Director |
SELL
Open market or private sale
|
Direct |
30,000
-37.45%
|
$3,540,000
$118.86 P/Share
|
|
Jan 03
2023
|
Stephen A Sherwin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+27.25%
|
$360,000
$12.85 P/Share
|
|
Jan 03
2023
|
Richard F Pops Director |
SELL
Open market or private sale
|
Direct |
15,000
-33.7%
|
$1,785,000
$119.2 P/Share
|
|
Jan 03
2023
|
Richard F Pops Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+25.21%
|
$180,000
$12.71 P/Share
|